Direct inhibition of matrix metalloproteinase-2 (MMP-2) by (−)-epigallocatechin-3-gallate: A possible role for the fibronectin type II repeats

Gene

Volumn 593, Issue 1, 2016, Pages 126-130

  Jha, Shalinee ^a   Kanaujia, Shankar Prasad ^a   Limaye, Anil M ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY GUWAHATI   (India)

Author keywords

Epigallocatechin 3 gallate; Fibronectin type II repeat; Green tea polyphenol; Matrix metalloproteinase 2; Molecular docking

Indexed keywords

BATIMASTAT; EPIGALLOCATECHIN GALLATE; FIBRONECTIN; FIBRONECTIN TYPE II REPEAT; FIBRONECTIN TYPE III REPEAT; GELATINASE A; GLYCINE; HEMOPEXIN; LEUCINE; MARIMASTAT; UNCLASSIFIED DRUG; ZINC; CATECHIN; MMP2 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVE SITE; ENZYME STRUCTURE; MOLECULAR DOCKING; PRIORITY JOURNAL; AMINO ACID REPEAT; ANALOGS AND DERIVATIVES; CHEMISTRY; HUMAN; MOLECULAR MODEL;

CATECHIN; HUMANS; MATRIX METALLOPROTEINASE 2; MODELS, MOLECULAR; REPETITIVE SEQUENCES, AMINO ACID;

EID: 84989813573     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2016.07.061     Document Type: Article

References (35)

1. Annabi, B., Lachambre, M.P., Bousquet-Gagnon, N., Page, M., Gingras, D., Beliveau, R., Green tea polyphenol (−)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells. Biochim. Biophys. Acta 1542 (2002), 209–220.
2. Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T.N., Weissig, H., Shindyalov, I.N., Bourne, P.E., The protein data Bank. Nucleic Acids Res. 28 (2000), 235–242.
3. Bhattacharya, D., Cheng, J., 3Drefine: consistent protein structure refinement by optimizing hydrogen bonding network and atomic-level energy minimization. Proteins 81 (2013), 119–131.
4. Chabottaux, V., Noel, A., Breast cancer progression: insights into multifaceted matrix metalloproteinases. Clin. Exp. Metastasis 24 (2007), 647–656.
5. Comeau, S.R., Gatchell, D.W., Vajda, S., Camacho, C.J., ClusPro: a fully automated algorithm for protein-protein docking. Nucleic Acids Res. 32 (2004), W96–W99.
6. Demeule, M., Brossard, M., Pagé, M., Gingras, D., Béliveau, R., Matrix metalloproteinase inhibition by green tea catechins. Biochim. Biophys. Acta 1478 (2000), 51–60.
7. Emsley, P., Lohkamp, B., Scott, W.G., Cowtan, K., Features and development of coot. Acta Crystallogr. D Biol. Crystallogr. 66 (2010), 486–501.
8. Fan, S.Q., Wei, Q.Y., Li, M.R., Zhang, L.Q., Liang, Q.C., Expression and clinical significance of MMP-2, MMP-9,TIMP-1, and TIMP-2 in breast carcinoma. Ai Zheng 22 (2003), 968–973.
9. Farabegoli, F., Papi, A., Orlandi, M., (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells. Biosci. Rep. 31 (2011), 99–108.
10. Garbisa, S., Sartor, L., Biggin, S., Salvato, B., Benelli, R., Albini, A., Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer 91 (2001), 822–832.
11. Kato, K., Long, N.K., Makita, H., Toida, M., Yamashita, T., Hatakeyama, D., Hara, A., Mori, H., Shibata, T., Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. Br. J. Cancer 99 (2008), 647–654.
12. La Rocca, G., Pucci-Minafra, I., Marrazzo, A., Taormina, P., Minafra, S., Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera. Br. J. Cancer 90 (2004), 1414–1421.
13. Laskowski, R.A., MacArthur, M.W., Moss, D.S., Thornton, J.M., PROCHECK — a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr., 26, 1993, 9.
14. Lauer-Fields, J.L., Whitehead, J.K., Li, S., Hammer, R.P., Brew, K., Fields, G.B., Selective modulation of matrix metalloproteinase 9 (MMP-9) functions via exosite inhibition. J. Biol. Chem. 283 (2008), 20087–20095.
15. Maeda-Yamamoto, M., Suzuki, N., Sawai, Y., Miyase, T., Sano, M., Hashimoto-Ohta, A., Isemura, M., Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells. J. Agric. Food Chem. 51 (2003), 1858–1863.
16. Mikhailova, M., Xu, X., Robichaud, T.K., Pal, S., Fields, G.B., Steffensen, B., Identification of collagen binding domain residues that govern catalytic activities of matrix metalloproteinase-2 (MMP-2). Matrix Biol. 31 (2012), 380–388.
17. Morris, G.M., Huey, R., Lindstrom, W., Sanner, M.F., Belew, R.K., Goodsell, D.S., Olson, A.J., AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 30 (2009), 2785–2791.
18. Nagase, H., Woessner, J.F., Matrix metalloproteinases. J. Biol. Chem. 274 (1999), 21491–21494.
19. Overall, C.M., Molecular determinants of metalloproteinase substrate specificity — matrix metalloproteinase substrate binding domains, modules, and exosites. Mol. Biotechnol. 22 (2002), 51–86.
20. Pacheco, M.M., Mourão, M., Mantovani, E.B., Nishimoto, I.N., Brentani, M.M., Expression of gelatinases A and B, stromelysin-3 and matrilysin genes in breast carcinomas: clinico-pathological correlations. Clin. Exp. Metastasis 16 (1998), 577–585.
21. Park, J.H., Yoon, J.H., Kim, S.A., Ahn, S.G., (−)-Epigallocatechin-3-gallate inhibits invasion and migration of salivary gland adenocarcinoma cells. Oncol. Rep. 23 (2010), 585–590.
22. Pellikainen, J.M., Ropponen, K.M., Kataja, V.V., Kellokoski, J.K., Eskelinen, M.J., Kosma, V.M., Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis. Clin. Cancer Res. 10 (2004), 7621–7628.
23. Rasmussen, H.S., McCann, P.P., Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat. Pharmacol. Ther. 75 (1997), 69–75.
24. Roomi, M.W., Ivanov, V., Kalinovsky, T., Niedzwiecki, A., Rath, M., Modulation of human renal cell carcinoma 786-0 MMP-2 and MMP-9 activity by inhibitors and inducers in vitro. Med. Oncol. 23 (2006), 245–250.
25. Roomi, M.W., Monterrey, J.C., Kalinovsky, T., Niedzwiecki, A., Rath, M., Modulation of MMP-2 and MMP-9 by cytokines, mitogens and inhibitors in lung cancer and malignant mesothelioma cell lines. Oncol. Rep. 22 (2009), 1283–1291.
26. Sen, T., Moulik, S., Dutta, A., Choudhury, P.R., Banerji, A., Das, S., Roy, M., Chatterjee, A., Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-a (MMP-2) in human breast cancer cell line MCF-7. Life Sci. 84 (2009), 194–204.
27. Sen, T., Dutta, A., Chatterjee, A., Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human breast cancer cell line MDA-MB-231. Anti-Cancer Drugs 21 (2010), 632–644.
28. Stankovic, S., Konjevic, G., Gopcevic, K., Jovic, V., Inic, M., Jurisic, V., Activity of MMP-2 and MMP-9 in sera of breast cancer patients. Pathol. Res. Pract. 206 (2010), 241–247.
29. Stetler-Stevenson, W.G., Aznavoorian, S., Liotta, L.A., Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9 (1993), 541–573.
30. Visse, R., Nagase, H., Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92 (2003), 827–839.
31. Winn, M.D., Ballard, C.C., Cowtan, K.D., Dodson, E.J., Emsley, P., Evans, P.R., Keegan, R.M., Krissinel, E.B., Leslie, A.G., McCoy, A., McNicholas, S.J., Murshudov, G.N., Pannu, N.S., Potterton, E.A., Powell, H.R., Read, R.J., Vagin, A., Wilson, K.S., Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 67 (2011), 235–242.
32. Xu, X., Wang, Y., Lauer-Fields, J.L., Fields, G.B., Steffensen, B., Contributions of the MMP-2 collagen binding domain to gelatin cleavage. Substrate binding via the collagen binding domain is required for hydrolysis of gelatin but not short peptides. Matrix Biol. 23 (2004), 171–181.
33. Yang, C.S., Wang, H., Mechanistic issues concerning cancer prevention by tea catechins. Mol. Nutr. Food Res. 55 (2011), 819–831.
34. Yang, C.S., Lambert, J.D., Hou, Z., Ju, J., Lu, G., Hao, X., Molecular targets for the cancer preventive activity of tea polyphenols. Mol. Carcinog. 45 (2006), 431–435.
35. Yang, C.S., Wang, H., Li, G.X., Yang, Z., Guan, F., Jin, H., Cancer prevention by tea: evidence from laboratory studies. Pharmacol. Res. 64 (2011), 113–122.